About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDNA

the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

The State of the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Patients With Exudative Age-Related Macular Degeneration

NCT07375901•The Filatov Institute of Eye Diseases and Tissue Therapy

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

AMD

Interventions

laser flare photometry before intravitreal injection

Locations

1

Ukraine

Locations (1)

The Filatov Institute of Eye Diseases and Tissue Therapy

Odesa, Ukraine

Key Dates

Start Date

March 25, 2021

Primary Completion Date

April 15, 2023

Completion Date

April 10, 2024

Last Updated

January 29, 2026

Related Studies

RECRUITINGPhase 3

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

NCT05407636

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

NCT07308639

Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)

RECRUITINGPhase 3

A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

NCT05562947

Neovascular Age-related Macular DegenerationnAMD

Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients With Exudative AMD (SINE)

NCT05547633

Lutein by Scleral Iontophoresis in AMD

NCT06925893

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

NCT06718816

Wet Age-related Macular Degeneration (wAMD)

View all related studies

Sponsors

Lead Sponsor

The Filatov Institute of Eye Diseases and Tissue Therapy

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions